Sanofi abandoned the development of amlitelimab in a deal involving Malin Corporation.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sanofi abandoned the development of amlitelimab in a deal involving Malin Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
French pharmaceutical company
Related events
Coverage
Newest first; wire copies grouped- irishtimes.comMalin misses out on $25.9m earnout as centrepiece drug key 2021 deal is scrapped